Bio-Rad Laboratories Class A
241 hedge funds and large institutions have $2.58B invested in Bio-Rad Laboratories Class A in 2015 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 85 increasing their positions, 86 reducing their positions, and 27 closing their positions.
240% more call options, than puts
Call options by funds: $1.19M | Put options by funds: $351K
3% more capital invested
Capital invested by funds: $2.5B → $2.58B (+$79.5M)
0.67% less ownership
Funds ownership: 78.77% → 78.1% (-0.67%)
1% less repeat investments, than reductions
Existing positions increased: 85 | Existing positions reduced: 86
4% less first-time investments, than exits
New positions opened: 26 | Existing positions closed: 27
1% less funds holding
Funds holding: 244 → 241 (-3)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$17.8M |
| 2 |
First Trust Advisors
Wheaton,
Illinois
|
+$15.2M |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
+$13.2M |
| 4 |
HSBC Holdings
London,
United Kingdom
|
+$10.4M |
| 5 |
Bank of Nova Scotia
Toronto,
Ontario, Canada
|
+$10.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BNP Paribas Financial Markets
Paris,
France
|
-$38.3M |
| 2 |
Millennium Management
New York
|
-$28.7M |
| 3 |
RA
Royce & Associates
New York
|
-$15M |
| 4 |
UBS AM
Chicago,
Illinois
|
-$14.7M |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$9.24M |
BIO Hedge Fund Activity: Q4 2015 in Review
241 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class A (BIO) for Q4 2015, worth a combined $2.58B — up 3.2% from $2.5B a quarter earlier.
Sellers outnumbered buyers: 27 funds closed out of BIO and 26 opened new positions — a net loss of 1 holder — while 86 trimmed existing stakes and 85 added.
The largest buyer was Credit Suisse, adding an estimated $17.8M. The largest seller was BNP Paribas Financial Markets, cutting an estimated $38.3M.
- 241 institutional investors held Bio-Rad Laboratories Class A (BIO) as of Q4 2015, down from 244 in Q3 2015.
- Funds reported $2.58B of Bio-Rad Laboratories Class A stock for Q4 2015, up 3.2% quarter-over-quarter.
- 26 funds opened new Bio-Rad Laboratories Class A positions in Q4 2015 and 27 closed out, a net change of -1 holder.
- The largest Bio-Rad Laboratories Class A buyer in Q4 2015 was Credit Suisse, an estimated $17.8M added.
- The largest Bio-Rad Laboratories Class A seller in Q4 2015 was BNP Paribas Financial Markets, an estimated $38.3M sold.
Based on aggregated 13F filings for Q4 2015.